PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
1.37
1.2–1.5 – Acceptable for many sectors. Peter Lynch might watch carefully for upcoming liabilities.
1.37
1.2–1.5 – Acceptable for many industries. Peter Lynch would want stable cash flows to avoid dipping below 1.
1.32
1.0–1.5 – Enough cash to cover all current liabilities. Seth Klarman would check if the business routinely hoards cash or invests it.
No Data
No Data available this quarter, please select a different quarter.
-46.77
Negative short-term coverage ratio usually means negative OCF or an outsized near-term debt – a major Graham red flag.